Dipeptidyl Peptidases as Survival Factors in Ewing Sarcoma Family of Tumors

A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature

(2010) Jeffrey D. Hancock et al.   CELL CYCLE

Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future

(2010) Joseph A Ludwig   CURRENT OPINION IN ONCOLOGY

The dipeptidyl peptidase IV family in cancer and cell biology

(2010) Denise M. T. Yu et al.   FEBS Journal

Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy

(2010) C Lu et al.   ONCOGENE

Calcium dysregulation induces apoptosis-inducing factor release: Cross-talk between PARP-1- and calpain- signaling pathways

(2009) Peter S. Vosler et al.   EXPERIMENTAL NEUROLOGY

Dipeptidyl peptidase 8 and 9 - guilty by association?

(2009) Melissa et al.   Frontiers in Bioscience-Landmark

Involvement of neuropeptide Y and its Y1 and Y5 receptors in maintaining self-renewal and proliferation of human embryonic stem cells

(2009) Mi-Young Son et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

DPP4 inhibitors for diabetes—What next?

(2008) Anne-Marie Lambeir et al.   BIOCHEMICAL PHARMACOLOGY

High Expression of Neuropeptide Y1 Receptors in Ewing Sarcoma Tumors

(2008) M. Korner et al.   CLINICAL CANCER RESEARCH

Stromal cell-derived factors 1α and 1β, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8

(2008) Katerina Ajami et al.   FEBS LETTERS

Microsatellites as EWS/FLI response elements in Ewing's sarcoma

(2008) K. Gangwal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The role of CD26/dipeptidyl peptidase IV in cancer

(2007) Pamela et al.   Frontiers in Bioscience-Landmark